MET exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features

被引：0
|
作者：
Yuan, Lisi [1 ]
Bosler, David [2 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin, Beachwood, OH USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1974
引用
收藏
页码：1831 / 1832
页数：2
相关论文
共 50 条
  • [41] MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy
    Wong, Selina K.
    Alex, Deepu
    Bosdet, Ian
    Hughesman, Curtis
    Karsan, Aly
    Yip, Stephen
    Ho, Cheryl
    LUNG CANCER, 2021, 154 : 142 - 145
  • [42] Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib
    Tan, Aaron C.
    Loh, Tracy J.
    Kwang, Xue Lin
    San Tan, Gek
    Lim, Kiat Hon
    Tan, Daniel S. W.
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 11 - 20
  • [43] The characteristics of MET exon 14 skipping mutations in Chinese non-small cell lung cancer: A retrospective analysis
    Zhu, Y.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 5 - 5
  • [44] Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients.
    Zhang, Baihua
    Xia, Yu
    Zhang, Jiujin
    Yu, Jin
    Chen, Min
    Yao, Wei
    Zhao, Juan
    He, Jiqiang
    Mok, Tony S. K.
    Wang, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Retrospective Analysis to Optimize the Detection of MET Exon 14 Skipping Mutations in Non-Small Cell Lung Cancer
    Lu, Jang-Jih
    Tsai, Shu-Hui
    Lin, Lee-Chung
    Chiueh, Tzong-Shi
    DIAGNOSTICS, 2024, 14 (11)
  • [46] Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report
    Chen, Zhuxing
    Zhu, Feng
    Li, Caichen
    Li, Jianfu
    Cheng, Bo
    Xiong, Shan
    Zhong, Ran
    Liang, Wenhua
    He, Jianxing
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (05)
  • [47] Clinical outcomes in advanced Non-Small Cell Lung Cancer (NSCLC) with MET exon 14 skipping mutation
    Smith, Miles
    Carter, Mat
    Woodhouse, Laura
    Adderley, Helen
    Morrissey, George
    Brown, Kate
    Nicola, Pantelis
    Weaver, Jamie
    Califano, Raffaele
    Summers, Yvonne
    Cove-Smith, Laura
    Hughes, Sarah
    Taylor, Paul
    Blackhall, Fiona
    Lindsay, Colin R.
    LUNG CANCER, 2024, 190
  • [48] Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer
    Ahn, Linda
    Alexander, Terri
    Vlassak, Soetkin
    Berghoff, Karin
    Lemmens, Liesbeth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (05) : 543 - 551
  • [49] Immunotherapy for stage IV non-small cell lung cancer patients with MET exon 14 skipping mutation
    Kuon, J.
    Blasi, M.
    Shah, R.
    Christopoulos, P.
    Stenzinger, A.
    Kazdal, D.
    Herth, F. J.
    Heussel, C. P.
    Thomas, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 172 - 172
  • [50] Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review
    Cortot, Alexis
    Le, Xiuning
    Smit, Egbert
    Viteri, Santiago
    Kato, Terufumi
    Sakai, Hiroshi
    Park, Keunchil
    Camidge, D. Ross
    Berghoff, Karin
    Vlassak, Soetkin
    Paik, Paul K.
    CLINICAL LUNG CANCER, 2022, 23 (03) : 195 - 207
12345